As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
On October 21, 2021, Shanghai Medicilon and Hangzhou MindRank signed a strategic agreement in Chuansha Park of Medicilon.
Chunlin Chen, Founder & CEO of Medicilon, Xuedong Dai, EVP of International R&D, Jinna Cai, Vice President of Business Development Department, Mingying Wang, Senior Director of Business Development Department, Zhangming Niu, Founder & CEO of MindRank, Long Zhang, Executive Vice President, and Qingzhen Yang, Deputy Director, Senior Medicinal Chemistry Scientist Wenxing Lu, Project Manager Xiaoyu Wang attended the signing ceremony and witnessed the signing together.
Medicilon has advanced PROTAC drug discovery and preclinical research technology and global operation experience, while MindRank has Molecule Dance™️ and Molecule Pro™️ artificial intelligence drug research and development platforms. In this cooperation, based on the resources and advantages in drug research and development and artificial intelligence, the two parties will provide more accurate, economical and efficient services for the research and development of First-in-class innovative drugs in the field of tumors.
Contact Us:
E-mail: marketing@medicilon.com
Share：
Relevant
news
marketing@medicilon.com
ABOUT
